Spago Nanomedical Announces Move to Go Private

Spago Nanomedical announced on October 24, 2026, that it intends to move from public to private status. The clinical-stage nanomedicine company described the move as a change to its corporate structure and public-market presence; the report provided no financial terms or stock-price impact.